BioNTech SE (BNTX)
NASDAQ • Healthcare
July 24, 2026 at 20:00 UTC
About BioNTech SE
BioNTech SE (NASDAQ: BNTX) is a biotechnology company focused on immune-based treatments for cancer and infectious disease, spanning oncology programs, infectious-disease immunotherapies, and protein replacement therapies for rare conditions. The company generated EUR 2.8 billion of revenue in FY2025, with principal operations in Mainz, Germany.
Analyst Ratings
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings Calendar
Technical Indicators
BioNTech SE's Technical Indicators Summary
BNTX shows a modest sell bias as short-term momentum has turned soft while longer-term averages remain above the current price, keeping downside pressure in place. Momentum indicators are muted to negative and the MACD is essentially flat, suggesting limited bullish conviction, while the ADX points to a weak trend and ATR indicates relatively low volatility. Volume metrics are unfavorable, with on-balance volume showing net distribution, and the classic pivot sits just above the market, offering nearby resistance. Technical takeaway: modest sell bias as price trades under key longer-term averages amid weak trend and soft momentum.
| Indicator | Value |
|---|---|
RSI (14) | 49.47 |
Stochastic %K (14, 3, 3) | 35.91 |
CCI (20) | -8.25 |
WPR (14) | -66.73 |
Momentum (10) | -1.70 |
MFI | 45.28 |
MACD Level (12, 26) | 0.02 |
Bollinger Bands | $88.73 - $96.10 |
ATR (14) | $2.35 (2.56%) |
ADX (14) | 12.94 |
OBV | -12,196,776 |
Classic Pivot Point | $92.68 |
Fibonacci Pivot Point | $92.68 |
Simple Moving Averages | $91.26 - $98.67(5 indicators) |
Exponential Moving Averages | $91.97 - $97.95(5 indicators) |
Get premium market insights delivered directly to your inbox.
Today's Snapshot
By the close, BNTX continued to reflect its -2.97% gap down versus yesterday. End-of-day, the peer group was modestly in the green at 0.69%, providing a small boost to sentiment. BNTX expands its European oncology footprint as Regional HPV E6.
Trading Volume
Above 10d avg 747.2K
881.2K
vs S&P 500 Today
Underperforming Market
-2.88%
52-Week Position
Lower range
22.1%
Updated: July 24, 2026 at 20:24 UTC
Quote Summary
BNTX Headlines
DACH-Focused Stock Moves Across Key Sectors
March 21, 2026
Markets Swoon as Bitcoin, Tech and Crypto Firms Slide
February 5, 2026